Takeaways From HHS Pharma Compliance Roundtable

Law360, New York (April 9, 2012, 1:40 PM EDT) -- On March 26, 2012, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services released a report summarizing its recent Pharmaceutical Compliance Roundtable.[1] The report provides a generally favorable account of the challenges and concerns raised by industry participants and the efforts they are making to implement effective compliance programs and comply with their respective Corporate Integrity Agreements (CIAs). Although the report implicitly validates industry concerns about the need for greater flexibility and about the costs associated with CIA requirements, it...
To view the full article, register now.